GET THE APP

..

Journal of Biomedical and Pharmaceutical Sciences

ISSN: 2952-8100

Open Access

Articles in press and Articles in process

      Editorial Note Pages: 1 - 1

      Stability Research on Drug

      Stephen T.Arbedon

      Share this article
      Editorial Note Pages: 1 - 1

      Scientific Components of Pharmaceutical Development

      Li-Pin Kao

      Share this article
          Perspective Pages: 1 - 1

          A broad-spectrum of Posaconazole against Fungal Infections

          Tosin Adetobi*

          Posaconazole is a pinch- generation triazole agent with a potent and broad antifungal in vitro exercise against a range of different Candida species, Aspergillus species, Cryptococcus neoformans, the zygomycetes, and other filamentous fungi. Rfungal pathogens, including Aspergillusspp. and Candida spp. It's structurally related to itraconazole and inhibits lanosterol 14α-demethylase (CYP51), blocking the compound of ergosterol behaving in disabled cell membrane stability and accumulation of precursors leading to fungistatic or fungicidal paraphernalia. Posaconazole (Noxafil, Schering Corporation, Kenilworth, NJ) was approved by the Food and Drug Administration for use as prophylaxis against invasive Aspergillus and Candida infections in immunocompromised case. Posaconazole differs in structure from the compact triazoles fluconazole and voriconazole in part by virtue of its extended side chain, a affection held in common with itraconazole.

          Editorial Pages: 1 - 1

          Editorial Note on Cancer Signs

          Kiran Shillewar*

          Cancer is the intemperate growth of abnormal cells anywhere in the body. These abnormal cells are baptized cancer cells, bitchy cells, or excrescence cells. These cells can insinuate normal body. Beaucoup cancers and the abnormal cells that compose the cancer are further associated by the name of that the abnormal cells appeared from (for case, blood cancer, lung cancer, and colorectal cancer). When damaged or unrepaired cells don't die and come cancer cells and show intemperate division and growth-a mass of cancer cells develop. Much, cancer cells can break out from this original mass of cells, travel through the blood and lymph systems, and lodge in other organs where they can again repeat the intemperate growth cycle. This process of cancer cells leaving an area and growing in another body area is baptized metastatic spread or metastasis. For case, if blood cancer cells spread to a bone, it means that the commodity has metastatic blood cancer to bone.What are risk factors and causes of cancer?

          Editorial Pages: 1 - 1

          Bipolar disorders-Recent advances in the fields of nosology, epidemiology, and molecular genetics

          Yia Liu*

          Bipolar diseases are serious, intellectual, chronic psychiatric diseases characterized by intermingling haps of mania or hypomania and depression, or composites of manic and
          depressive features. The weekly frequence of bipolar diseases ranges from 3 to 10 cases per population, and the life frequency is estimated to be 3 to7.2 million. Bipolar Disease (BD), also known as manic-depressive illness, is a serious illness that causes unusual shifts in mood, energy, exercise ranks, and the incompetence to carry out day-moment tasks. Treatment of BD generally begins with the idea of bringing a case with mania or depression to distinct recovery and stable mood. Once the existent is stable, the idea progresses to reducing subthreshold  symptoms of mania and depression. Medicinal treatments have several purposes. Some medicinals aims to reduce symptoms
          associated with acute manic or mixed mania/ depression happenings, some idea to reduce acute depression symptoms, and others aim to reduce acute symptoms, maintain like symptom-free days, and forestall relapsing to acute happenings. Given the confirmed, relapsing/ remitting course of bipolar complication and the need for conserving treatment in multifold cases, medicinals begun for an acute mood hap (including mania) are hourly carried forward into conserving curative.

            Research Article Pages: 1 - 4

            Isolation and Molecular Characterization Of Aspergillus fumigatus From Hunting Dogs With Special Emphasis To Age And Gender As A Risk Factors In Diyala Province â??Iraq

            Ali Ibrahim Ali Al-Ezzy , Sarah Jasim Abdulameer

            Aim: The current study aims to isolation and molecular characterization of A. fumigatus from hunting dogs and evaluation of relationship between A. fumigatus infection and possible risk factors mainly age and gender Methods: Ninety nine swabs from mouth, nose and ear of hunting dogs with respiratory signs were cultured on Sabouraud Dextrose Agar. A. fumigatus was identified according to morphology and PCR technique Results: A.fumigatus was isolated frequently from mouth of hunting dogs at the age group (5.4 -6.2) years followed by (0.6-1.5) years and (2.5-3.3)years,(6.06%) . A.fumigatus was isolated equally from nose of hunting dogs at the age group (0.6-1.5)years ,(1.6-2.4 ) years , ( 2.5-3.3 )years,( 4.3-5.3) years and (5.4-6.2) years, (3.03%). A.fumigatus was isolated frequently from ear of hunting dogs at the age group (5.4-6.2)years;(9.09%). No significant difference was reported between age groups of hunting dogs infected with A.fumigatus . Significant correlation was reported between older age group of hunting dogs and A.fumigatus infection for ear. Current study revealed that (63.64%) of hunting dogs were males while female represent (36.36%).Both genders were equally infected with A.fumigatus isolated from mouth and nose, (15.15%) and (6.06%) respectively .Females were infected more than males with A.fumigatus isolated from ear,(6.06%) Neither significant difference nor correlation were reported between genders of hunting dogs infected with A.fumigatus. Males appear to be at risk of getting A.fumigatus infection at( 2.286) time than females. Conclusions: A. fumigatus infection represent serious problem for hunting dogs . Mouth, nose and ear respectively exposed.

              Commentary Pages: 1 - 2

              Pharmacognosy : significance

              Shash Zhao*

              Share this article
              Commentary Pages: 1 - 2

              Introduction Virulence Factor Commentary

              Stephen T Arbedon

              Some are chromosomally encoded and natural for the microbes for example cases and endotoxin, though others are gotten from versatile hereditary components like plasmids and bacteriophages for example a few exotoxins. Destructiveness factors encoded on versatile hereditary components spread through flat quality exchange, and can change over innocuous microscopic organisms into perilous microbes. Microorganisms like Escherichia coli O157:H7 acquire most of their harmfulness from portable hereditary components. Gram-negative microbes discharge an assortment of destructiveness factors at have microorganism interface, through layer vesicle dealing as bacterial external film vesicles for intrusion, sustenance and other cell-cell interchanges.

                Editorial Pages: 1 - 1

                Physiologically Based Pharmacokinetic Modeling

                Lesli E. Deker

                Physiologically based pharmacokinetic modeling is a mathematical modeling technique for predicting the absorption, distribution, metabolism and excretion of synthetic or natural chemical substances in humans and other animal species. PBPK modeling is used in pharmaceutical research and drug development, and in health risk assessment for cosmetics or general chemicals. PBPK models strive to be mechanistic by mathematically transcribing anatomical, physiological, physical, and chemical descriptions of the phenomena involved in the complex ADME processes.

                Commentary Pages: 1 - 1

                Clinical Usage of Minimum Inhibitory Concentration

                Xiang-Hai ai

                Nowadays, the is used in antimicrobial susceptibility testing. The is reported by providing the susceptibility interpretation next to each antibiotic. The different susceptibility interpretations are: S Sensitive, I Intermediate, and These interpretations were created and implemented by the Clinical and Laboratory Standards Institute. In clinics, more often than not, exact pathogens cannot be easily determined by symptoms of the patient. Then, even if the pathogen is determined, different serotypes of pathogens, such as Staphylococcus aureus, have varying levels of resistance to antimicrobials.

arrow_upward arrow_upward